Open Forum Infectious Diseases

I think my role is really just helping people and helping authors make their manuscripts better.

And OFID has a special place in my heart.

And when Cindy came on to be the editor-in-chief of JID and offered me a role, I jumped at that opportunity.

Well, John, thanks a lot.

And thank you for abbreviating it correctly.

It's OFID, not OFID.

So I'm going to ask you now, when you took this position on, this is a new position for you, what did you hope to preserve and what did you want to change when you took over? Cindy, let's hear from you.

Yeah, obviously, I wanted to continue the tradition of excellent science that JID has represented for more than 100 years, pushing 125 years in our field.

All right.

And this next article I grabbed from OFID, Cefalexin Model-Informed Dosing Recommendations for Severe Infections, a Pooled Pharmacokinetic Analysis from Infancy to Adulthood.

So what is the optimal dosing for cefalexin, aka Cleflex? The FDA-approved dosing is 25 to 50 mg per kg per day.

So that's divided for pediatric patients over the age of one.

All right.

I grabbed a paper from OFID, a scenario-based survey of clinician recommendations for follow-up blood cultures in patients with varying risk of persistent gram-negative bacteremia.

So the authors here had created a survey that had 10, I think it was 10 vignettes, um, where clinicians had to provide recommendations on follow-up blood cultures.

This was an international survey, so majority of the respondents were from the US, about 62%.

And then we will move into our fungal section.

You know, I probably should stop grabbing papers that I feel like I already [laughs] knew the answer to.

But, um, this one I grabbed from OFID, No Survival Benefit Associated With Antifungal Therapy For Respiratory Candida Species: A Single-Center Retrospective Cohort Study.

I just, um, love this.